# RIBOCICLIB
> **ANDA215677** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC PHARMS LTD · Approved 2024-01-10
## Drug
- **FDA Application Number:** ANDA215677
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIBOCICLIB
- **Generic name:** Ribociclib
- **Active ingredients:** RIBOCICLIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ALEMBIC PHARMS LTD
- **First approval:** 2024-01-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215677)
---
*AI Analytics · CC0 1.0*